Contrarius Investment Management’s Intellia Therapeutics NTLA Stock Holding History

Contrarius Investment Management’s Portfolio NTLA Stock Details NTLA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$42.1M	Buy
2024 Q2	$42.9M	Buy
2024 Q1	$37.2M	Buy
2023 Q4	$6.54M	Sell
2023 Q3	$7.33M	Sell
2023 Q2	$12M	Buy